Jason Drew Smith - 28 Jul 2025 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
General Counsel
Signature
/s/ Jason D. Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
28 Jul 2025
Net transactions value
-$143,971
Form type
4
Filing time
30 Jul 2025, 16:03:45 UTC
Previous filing
04 Feb 2025
Next filing
09 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Smith Jason Drew General Counsel 400 ALEXANDER PARK DRIVE, PRINCETON /s/ Jason D. Smith, Attorney-in-Fact 30 Jul 2025 0001821479

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise +16,500 +51% 49,014 28 Jul 2025 Direct F1, F2
transaction URGN Ordinary Shares Sale $143,971 -7,522 -15% $19.14 41,492 28 Jul 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the settlement of performance stock units granted on January 31, 2024 that vested upon the achievement of a corporate milestone event.
F2 Each performance stock unit represents a contingent right to receive one ordinary share of the Issuer.
F3 Represents shares sold to satisfy withholding tax obligations upon the settlement of performance stock units.